I-Mab
Anti-LAG-3 antibodies and uses thereof

Last updated:

Abstract:

The present disclosure provides antibodies that bind Lymphocyte Activation Gene-3 (LAG-3). Also provided are methods of stimulating an immune response, inhibiting growth of tumor cells, and treating an autoimmune, inflammatory, or viral disease.

Status:
Grant
Type:

Utility

Filling date:

22 Feb 2018

Issue date:

3 Mar 2020